HomeAbout

TL;DR CNBC


Eli Lilly recruits Black patients for Alzheimer's trial, as drugmakers seek more diversity in clinical studies - TL;DR CNBC

Eli Lilly recruits Black patients for Alzheimer's trial, as drugmakers seek more diversity in clinical studies

Publishing timestamp: 2023-02-16 16:02:11


Summary

Drugmakers are using more direct approaches to boost diversity in clinical trials, such as mobile testing labs, social media recruitment, and pharmacy clinics. Eli Lilly drove two mobile labs to a Black Women's Expo to recruit older Black women for a new trial. This has helped build trust in communities of color, which have traditionally been underrepresented in clinical research. Retailers such as CVS Health, Walgreens, and Kroger have announced initiatives to provide clinical trial enrollment and follow-up services in their pharmacy clinics. Pfizer CEO Albert Bourla says social media has become a useful way to recruit participants. The FDA has encouraged drugmakers to broaden criteria for enrolling trial participants to increase diversity.


Sentiment: POSITIVE

Tickers: WBALLYPFEKRCVS

Keywords: pharmacy operatorsbiotech and pharmaceuticalsbusiness newseli lilly and copfizer incfdabiotechnologyhealth care industrywalgreens boots alliance incalzheimer's diseasekroger copharmaceuticalscvs health corpbusiness

Source: https://www.cnbc.com/2023/02/16/eli-lilly-recruits-black-patients-for-alzheimer-trial-as-drugmakers-seek-diversity-in-clinical-studies.html


Developed by Leo Phan